A novel indole alkaloid from deep-sea sediment metagenomic clone-derived Escherichia coli fermentation broth.

Lin Chen,Xi-Xiang Tang,Min Zheng,Zhi-Wei Yi,Xiang Xiao,Ying-Kun Qiu,Zhen Wu
DOI: https://doi.org/10.1080/10286020.2011.570262
2011-01-01
Journal of Asian Natural Products Research
Abstract:To explore secondary metabolites in deep-sea sediment metagenomic clone-derived Escherichia coli fermentation broth, different kinds of chromatography methods were used in the isolation procedures, while the structures of the isolated compounds were assigned based on the MS analysis and their 1H and 13C NMR spectra including 2D NMR techniques such as COSY, HMQC, and HMBC experiments. As a result, a novel compound was isolated and characterized as N-{1-[4-(acetylamino)phenyl]-3-hydroxy-1-(1H-indol-3-yl)propan-2-yl}-2,2-dichloroacetamide (1). In addition, eight known compounds were also obtained. Fatty acid amide hydrolase and monoacylglycerol lipase were used to screen analgesic activity, and the new compound showed analgesic activity to some extent in pharmacological test.
What problem does this paper attempt to address?